Blue Ribbon Panel to Help Guide Cancer Moonshot Initiative

Get Permission

As described in the full report on page 39, the National Cancer Institute (NCI) announced a Blue Ribbon Panel of experts and advocates who will inform the scientific direction and goals at NCI of Vice President Joe Biden’s National Cancer Moonshot Initiative. Members of the research community and the public can engage in the initiative by subscribing to updates at or by e-mailing the panel at

Blue Ribbon Panel Members

  • Tyler Jacks, PhD (Co-Chair), Chair, National Cancer Advisory Board, and Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • Elizabeth Jaffee, MD (Co-Chair), Professor and Deputy Director for Translational Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
  • Dinah Singer, PhD (Co-Chair), Acting Deputy Director and Division of Cancer Biology Director, NCI
  • Peter Adamson, MD, Professor and Director, Experimental Therapeutics in Oncology, The Children’s Hospital of Philadelphia
  • James Allison, PhD, Professor and Chair of Immunology, University of Texas MD Anderson Cancer Center
  • David Arons, JD, Chief Executive Officer, National Brain Tumor Society
  • Mary Beckerle, PhD, CEO and Director, Huntsman Cancer Institute
  • Mitch Berger, MD, Professor and Chair, Department of Neurological Surgery, University of California, San Francisco (UCSF)
  • Jeff Bluestone, PhD, A.W. and Mary Margaret Clausen Distinguished Professor, UCSF
  • Mikael Dolsten, MD, PhD, President, Pfizer Worldwide Research and Development, and Executive Vice President, Pfizer, Inc
  • James Downing, MD, President and CEO, St. Jude Children’s Research Hospital
  • Levi Garraway, MD, PhD, Associate Professor of Medicine, Harvard Medical School, and Assistant Professor of Medicine, Dana-Farber Cancer Institute
  • Gad Getz, PhD, Director, Cancer Genome Computational Analysis and Institute Member, Broad Institute; Director, Bioinformatics Program, Massachusetts General Hospital (MGH) Cancer Center and Department of Pathology; Associate Professor of Pathology, Harvard Medical School; Paul C. Zamecnik Chair in Oncology, MGH Cancer Center
  • Laurie Glimcher, MD, Professor of Medicine and Dean, Weill Cornell Medical College, and Incoming President and CEO, Dana-Farber Cancer Institute
  • Lifang Hou, MD, PhD, Associate Professor of Preventive Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
  • Neal Kassell, MD, Professor of Neurosurgery, University of Virginia
  • Maria Elena Martinez, PhD, Professor of Family Medicine and Public Health, Reducing Cancer Disparities Program, UC San Diego Moores Cancer Center
  • Deborah Mayer, PhD, RN, Professor of Adult and Geriatric Health, University of North Carolina School of Nursing, and Director of Cancer Survivorship, UNC Lineberger Comprehensive Cancer Center
  • Edith Mitchell, MD, FACP, Professor of Medical Oncology and Associate Director for Diversity Services, Sidney Kimmel Cancer Center at Thomas Jefferson University
  • Augusto Ochoa, MD, Professor of Pediatrics and Director, Stanley S. Scott Cancer Center, Louisiana State University
  • Jennifer Pietenpol, PhD, Professor of Oncology, Professor of Biochemistry, and Director, Vanderbilt-Ingram Cancer Center
  • Angel Pizarro, MSE, Technical Business Development Manager, Amazon Web Services Scientific Computing and Research Computing
  • Barbara Rimer, DrPH, Alumni Distinguished Professor and Dean, University of North Carolina Gillings School of Global Public Health
  • Charles Sawyers, MD, Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, and Investigator, Howard Hughes Medical Institute
  • Ellen Sigal, PhD, Founder and Chair, Friends of Cancer Research
  • Patrick Soon-Shiong, MBBCh, Founder, Chair, CEO, NantWorks LLC
  • Chi Van Dang, MD, PhD, Professor of Medicine and Director, Abramson Cancer Center, University of ­Pennsylvania
  • Wai-Kwan Alfred Yung, MD, Professor of Neuro-Oncology and holder of the Margaret and Ben Love Chair of Clinical Cancer Care, University of Texas MD Anderson Cancer Center ■





By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.